Thomas A. Mavrakanas

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients

Thomas A. Mavrakanas, Caroline Samer, Sharon J. Nessim et al. · Journal of the American Society of Nephrology · 2017 · 216 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation

Thomas A. Mavrakanas, Katherine Garlo, David M. Charytan · Clinical Journal of the American Society of Nephrology · 2020 · 96 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline

Linan Zeng, Michael Walsh, Gordon Guyatt et al. · BMJ · 2022 · 58 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography

Thomas A. Mavrakanas, Aisha Khattak, Karandeep Singh et al. · Clinical Journal of the American Society of Nephrology · 2017 · 48 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Childhood obesity and elevated blood pressure in a rural population of northern Greece

Thomas A. Mavrakanas, Georgia Konsoula, Ioannis Patsonis et al. · Rural and Remote Health · 2009 · 39 citations · Full text

Medicine, Child Health, Pediatrics +13